Nuvo Research Inc. is a specialty pharmaceutical company. The Company is engaged in building a portfolio of products for the treatment of pain through internal research and development (R&D), in-licensing and acquisition. The Company�s product portfolio includes Pliaglis and Synera. Through its subsidiary Nuvo Research AG, the Company is also developing the compound WF10, for the treatment of immune related diseases. The Company�s Pain Group located in West Chester, Pennsylvania is focused on the development and commercialization of topically delivered pain products, including Pennsaid.